| 0 |
VESSEL PUNCTURE SITE PHLEBITIS |
1 |
0.2500 |
| 1 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED RECURRENT |
15 |
0.2239 |
| 2 |
SALIVARY DUCT INFLAMMATION |
1 |
0.0435 |
| 3 |
VASCULAR ACCESS SITE THROMBOSIS |
2 |
0.0400 |
| 4 |
UVEAL MELANOMA |
1 |
0.0179 |
| 5 |
PNEUMOCOCCAL BACTERAEMIA |
2 |
0.0159 |
| 6 |
URINARY SEDIMENT ABNORMAL |
1 |
0.0156 |
| 7 |
PHLEBITIS INFECTIVE |
1 |
0.0139 |
| 8 |
TRACHEAL INFLAMMATION |
1 |
0.0092 |
| 9 |
INFESTATION |
2 |
0.0077 |
| 10 |
ELECTROCARDIOGRAM QT INTERVAL |
1 |
0.0069 |
| 11 |
NONINFECTIVE SIALOADENITIS |
1 |
0.0063 |
| 12 |
CELLULITE |
2 |
0.0061 |
| 13 |
INJECTION SITE THROMBOSIS |
2 |
0.0061 |
| 14 |
MENINGOENCEPHALITIS VIRAL |
1 |
0.0056 |
| 15 |
HYPOTHALAMIC PITUITARY ADRENAL AXIS SUPPRESSION |
2 |
0.0056 |
| 16 |
PENILE INFECTION |
1 |
0.0052 |
| 17 |
SALMONELLA BACTERAEMIA |
1 |
0.0048 |
| 18 |
LICE INFESTATION |
1 |
0.0048 |
| 19 |
SCROTAL INFECTION |
1 |
0.0048 |
| 20 |
INFUSION SITE PHLEBITIS |
1 |
0.0044 |
| 21 |
MUCOSAL INFECTION |
1 |
0.0043 |
| 22 |
TRACHEAL OBSTRUCTION |
1 |
0.0038 |
| 23 |
OVARIAN CANCER METASTATIC |
3 |
0.0035 |
| 24 |
LACUNAR STROKE |
1 |
0.0031 |
| 25 |
BRAIN MASS |
1 |
0.0030 |
| 26 |
NON-CARDIAC CHEST PAIN |
9 |
0.0028 |
| 27 |
VASCULAR ACCESS COMPLICATION |
2 |
0.0025 |
| 28 |
LYMPHOCYTIC LEUKAEMIA |
1 |
0.0025 |
| 29 |
RED BLOOD CELL TRANSFUSION |
1 |
0.0024 |
| 30 |
OVARIAN CANCER STAGE IV |
1 |
0.0024 |
| 31 |
ADRENAL SUPPRESSION |
2 |
0.0024 |
| 32 |
PSEUDOMONAL BACTERAEMIA |
2 |
0.0023 |
| 33 |
OESOPHAGEAL INFECTION |
1 |
0.0022 |
| 34 |
ENTEROCOLITIS INFECTIOUS |
2 |
0.0022 |
| 35 |
PLICATED TONGUE |
1 |
0.0021 |
| 36 |
URINARY TRACT PAIN |
1 |
0.0020 |
| 37 |
ACQUIRED IMMUNODEFICIENCY SYNDROME |
1 |
0.0019 |
| 38 |
PNEUMONIA STREPTOCOCCAL |
2 |
0.0018 |
| 39 |
RETINOPATHY OF PREMATURITY |
1 |
0.0018 |
| 40 |
PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED |
1 |
0.0017 |
| 41 |
HYPOPHOSPHATAEMIA |
12 |
0.0016 |
| 42 |
HYPERMAGNESAEMIA |
1 |
0.0015 |
| 43 |
ASPIRATION PLEURAL CAVITY |
1 |
0.0013 |
| 44 |
SUPERINFECTION BACTERIAL |
1 |
0.0013 |
| 45 |
EMBOLISM |
10 |
0.0012 |
| 46 |
CULTURE POSITIVE |
1 |
0.0012 |
| 47 |
MALIGNANT PLEURAL EFFUSION |
2 |
0.0012 |
| 48 |
PHLEBITIS |
6 |
0.0012 |
| 49 |
HYPOMAGNESAEMIA |
16 |
0.0011 |
| 50 |
THROMBOPHLEBITIS |
4 |
0.0011 |
| 51 |
BONE MARROW TRANSPLANT |
2 |
0.0011 |
| 52 |
PERIPHERAL SENSORY NEUROPATHY |
6 |
0.0010 |
| 53 |
HYPOFIBRINOGENAEMIA |
1 |
0.0010 |
| 54 |
ADMINISTRATION SITE EXTRAVASATION |
1 |
0.0010 |
| 55 |
IMMUNE-MEDIATED DERMATITIS |
1 |
0.0010 |
| 56 |
NEUTROPENIC COLITIS |
2 |
0.0010 |
| 57 |
METASTASES TO PLEURA |
1 |
0.0010 |
| 58 |
NASAL INFLAMMATION |
1 |
0.0009 |
| 59 |
LYMPHOCYTE COUNT DECREASED |
16 |
0.0009 |
| 60 |
BENIGN NEOPLASM |
1 |
0.0009 |
| 61 |
IMMUNE-MEDIATED HYPOTHYROIDISM |
1 |
0.0009 |
| 62 |
RECTAL ULCER |
1 |
0.0009 |
| 63 |
HYPOCALCAEMIA |
16 |
0.0008 |
| 64 |
PHYSICAL PRODUCT LABEL ISSUE |
1 |
0.0008 |
| 65 |
SUBCUTANEOUS ABSCESS |
4 |
0.0008 |
| 66 |
GRANULOMATOSIS WITH POLYANGIITIS |
1 |
0.0008 |
| 67 |
MALLORY-WEISS SYNDROME |
1 |
0.0008 |
| 68 |
SINUS TACHYCARDIA |
11 |
0.0008 |
| 69 |
TUMOUR PAIN |
1 |
0.0008 |
| 70 |
SIALOADENITIS |
1 |
0.0007 |
| 71 |
PERIPHERAL MOTOR NEUROPATHY |
1 |
0.0007 |
| 72 |
BRONCHIAL OBSTRUCTION |
1 |
0.0007 |
| 73 |
FEBRILE BONE MARROW APLASIA |
3 |
0.0007 |
| 74 |
DYSPNOEA AT REST |
2 |
0.0007 |
| 75 |
SEBORRHOEIC KERATOSIS |
1 |
0.0007 |
| 76 |
RHINITIS ALLERGIC |
3 |
0.0007 |
| 77 |
ILEUS PARALYTIC |
3 |
0.0007 |
| 78 |
EMBOLISM VENOUS |
2 |
0.0007 |
| 79 |
DISEASE PROGRESSION |
77 |
0.0007 |
| 80 |
LOCALISED OEDEMA |
3 |
0.0006 |
| 81 |
HYPERTROPHIC CARDIOMYOPATHY |
1 |
0.0006 |
| 82 |
FUNGAEMIA |
1 |
0.0006 |
| 83 |
AORTIC VALVE DISEASE |
1 |
0.0006 |
| 84 |
ACUTE LEUKAEMIA |
1 |
0.0006 |
| 85 |
FAILURE TO THRIVE |
3 |
0.0006 |
| 86 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
9 |
0.0006 |
| 87 |
MITRAL VALVE DISEASE |
1 |
0.0006 |
| 88 |
NEUTROPHIL COUNT DECREASED |
23 |
0.0006 |
| 89 |
JUGULAR VEIN THROMBOSIS |
1 |
0.0006 |
| 90 |
THROMBOCYTOSIS |
2 |
0.0005 |
| 91 |
OESOPHAGEAL SPASM |
1 |
0.0005 |
| 92 |
RHEUMATIC DISORDER |
1 |
0.0005 |
| 93 |
HYPOALBUMINAEMIA |
4 |
0.0005 |
| 94 |
RHINOVIRUS INFECTION |
2 |
0.0005 |
| 95 |
HYPERTRIGLYCERIDAEMIA |
3 |
0.0005 |
| 96 |
EXTRAVASATION |
2 |
0.0005 |
| 97 |
CD4 LYMPHOCYTES DECREASED |
1 |
0.0005 |
| 98 |
HYPERPHOSPHATAEMIA |
1 |
0.0005 |
| 99 |
ELECTROCARDIOGRAM ST SEGMENT DEPRESSION |
1 |
0.0005 |
| 100 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
11 |
0.0004 |
| 101 |
DISEASE COMPLICATION |
2 |
0.0004 |
| 102 |
HYPOXIA |
15 |
0.0004 |
| 103 |
TRANSPLANT |
1 |
0.0004 |
| 104 |
SUPRAVENTRICULAR TACHYCARDIA |
4 |
0.0004 |
| 105 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
3 |
0.0004 |
| 106 |
SYSTEMIC CANDIDA |
1 |
0.0004 |
| 107 |
CANCER PAIN |
1 |
0.0004 |
| 108 |
INFUSION SITE PAIN |
5 |
0.0004 |
| 109 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 110 |
RHINALGIA |
1 |
0.0004 |
| 111 |
PLEURITIC PAIN |
1 |
0.0004 |
| 112 |
VITREOUS HAEMORRHAGE |
1 |
0.0004 |
| 113 |
ENDOTRACHEAL INTUBATION |
1 |
0.0004 |
| 114 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 115 |
NEUTROPHILIA |
2 |
0.0004 |
| 116 |
HYPOKALAEMIA |
16 |
0.0003 |
| 117 |
PLEURISY |
2 |
0.0003 |
| 118 |
ANAL INCONTINENCE |
3 |
0.0003 |
| 119 |
HYPERCALCAEMIA |
4 |
0.0003 |
| 120 |
INFUSION SITE EXTRAVASATION |
2 |
0.0003 |
| 121 |
INVESTIGATION |
1 |
0.0003 |
| 122 |
LOSS OF THERAPEUTIC RESPONSE |
1 |
0.0003 |
| 123 |
SINUS BRADYCARDIA |
3 |
0.0003 |
| 124 |
PLATELET COUNT DECREASED |
33 |
0.0003 |
| 125 |
VULVOVAGINAL DRYNESS |
1 |
0.0003 |
| 126 |
ELECTROCARDIOGRAM QT PROLONGED |
11 |
0.0003 |
| 127 |
HYPONATRAEMIA |
17 |
0.0003 |
| 128 |
PEPTIC ULCER |
1 |
0.0003 |
| 129 |
LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV |
1 |
0.0003 |
| 130 |
BLOOD BILIRUBIN INCREASED |
8 |
0.0003 |
| 131 |
LYMPHOEDEMA |
2 |
0.0003 |
| 132 |
HYPOPNOEA |
1 |
0.0003 |
| 133 |
CLOSTRIDIUM DIFFICILE COLITIS |
3 |
0.0003 |
| 134 |
HYPERGLYCAEMIA |
10 |
0.0003 |
| 135 |
ASPIRATION |
3 |
0.0003 |
| 136 |
ORAL PAIN |
6 |
0.0003 |
| 137 |
INTESTINAL PERFORATION |
3 |
0.0003 |
| 138 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 139 |
PARANASAL SINUS DISCOMFORT |
1 |
0.0003 |
| 140 |
THERAPEUTIC PRODUCT INEFFECTIVE |
1 |
0.0003 |
| 141 |
ANAEMIA |
49 |
0.0003 |
| 142 |
SKIN LESION |
7 |
0.0003 |
| 143 |
PROSTATOMEGALY |
1 |
0.0003 |
| 144 |
ASPARTATE AMINOTRANSFERASE INCREASED |
13 |
0.0002 |
| 145 |
HYPERURICAEMIA |
1 |
0.0002 |
| 146 |
UPPER-AIRWAY COUGH SYNDROME |
2 |
0.0002 |
| 147 |
GENERALISED OEDEMA |
3 |
0.0002 |
| 148 |
FEBRILE NEUTROPENIA |
16 |
0.0002 |
| 149 |
BUNDLE BRANCH BLOCK LEFT |
1 |
0.0002 |
| 150 |
HEPATIC PAIN |
1 |
0.0002 |
| 151 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 152 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 153 |
NAIL DISORDER |
2 |
0.0002 |
| 154 |
ORAL CANDIDIASIS |
3 |
0.0002 |
| 155 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
1 |
0.0002 |
| 156 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 157 |
RASH MACULO-PAPULAR |
5 |
0.0002 |
| 158 |
IRON DEFICIENCY |
1 |
0.0002 |
| 159 |
WHITE BLOOD CELL COUNT DECREASED |
24 |
0.0002 |
| 160 |
SKIN ABRASION |
1 |
0.0002 |
| 161 |
INFUSION RELATED REACTION |
14 |
0.0002 |
| 162 |
VULVOVAGINAL PAIN |
1 |
0.0002 |
| 163 |
HOSPICE CARE |
2 |
0.0002 |
| 164 |
HYPERNATRAEMIA |
1 |
0.0002 |
| 165 |
ERYSIPELAS |
1 |
0.0002 |
| 166 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 167 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
1 |
0.0002 |
| 168 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
2 |
0.0002 |
| 169 |
PERIORBITAL OEDEMA |
1 |
0.0002 |
| 170 |
NEUTROPENIA |
26 |
0.0002 |
| 171 |
MUCOSAL INFLAMMATION |
5 |
0.0002 |
| 172 |
OBESITY |
3 |
0.0002 |
| 173 |
BREAST CANCER METASTATIC |
2 |
0.0002 |
| 174 |
COLITIS |
7 |
0.0002 |
| 175 |
HYDROCEPHALUS |
1 |
0.0002 |
| 176 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
4 |
0.0002 |
| 177 |
ALANINE AMINOTRANSFERASE INCREASED |
11 |
0.0002 |
| 178 |
SKIN ATROPHY |
1 |
0.0002 |
| 179 |
HERPES VIRUS INFECTION |
1 |
0.0002 |
| 180 |
MOUTH SWELLING |
1 |
0.0002 |
| 181 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 182 |
ASCITES |
5 |
0.0002 |
| 183 |
THROMBOCYTOPENIA |
19 |
0.0002 |
| 184 |
HEARING IMPAIRED |
1 |
0.0002 |
| 185 |
HEPATITIS B |
1 |
0.0002 |
| 186 |
DERMATITIS ACNEIFORM |
1 |
0.0002 |
| 187 |
SMALL INTESTINAL OBSTRUCTION |
2 |
0.0002 |
| 188 |
NASAL DRYNESS |
1 |
0.0002 |
| 189 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 190 |
PHOTOPSIA |
1 |
0.0002 |
| 191 |
ACUTE RESPIRATORY FAILURE |
3 |
0.0002 |
| 192 |
PLATELET COUNT INCREASED |
2 |
0.0002 |
| 193 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 194 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 195 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 196 |
GASTROOESOPHAGEAL REFLUX DISEASE |
12 |
0.0001 |
| 197 |
SEPSIS |
16 |
0.0001 |
| 198 |
LYMPHOPENIA |
2 |
0.0001 |
| 199 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 200 |
BLOOD CREATININE INCREASED |
9 |
0.0001 |
| 201 |
MOUTH HAEMORRHAGE |
1 |
0.0001 |
| 202 |
ARTHROPOD BITE |
1 |
0.0001 |
| 203 |
LIPASE INCREASED |
1 |
0.0001 |
| 204 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 205 |
MUSCULOSKELETAL CHEST PAIN |
2 |
0.0001 |
| 206 |
APHTHOUS ULCER |
1 |
0.0001 |
| 207 |
EJECTION FRACTION DECREASED |
2 |
0.0001 |
| 208 |
CONSTIPATION |
28 |
0.0001 |
| 209 |
THERAPY PARTIAL RESPONDER |
2 |
0.0001 |
| 210 |
CYANOSIS |
2 |
0.0001 |
| 211 |
GINGIVAL PAIN |
1 |
0.0001 |
| 212 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 213 |
DECUBITUS ULCER |
1 |
0.0001 |
| 214 |
HICCUPS |
1 |
0.0001 |
| 215 |
ESCHERICHIA INFECTION |
1 |
0.0001 |
| 216 |
DYSGEUSIA |
9 |
0.0001 |
| 217 |
CYTOMEGALOVIRUS INFECTION |
2 |
0.0001 |
| 218 |
BLOOD UREA INCREASED |
2 |
0.0001 |
| 219 |
INFUSION SITE ERYTHEMA |
1 |
0.0001 |
| 220 |
HAEMATURIA |
4 |
0.0001 |
| 221 |
SKIN HYPERPIGMENTATION |
1 |
0.0001 |
| 222 |
INJECTION SITE REACTION |
8 |
0.0001 |
| 223 |
SKIN ULCER |
3 |
0.0001 |
| 224 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 225 |
PURPURA |
1 |
0.0001 |
| 226 |
LYMPHADENOPATHY |
4 |
0.0001 |
| 227 |
ATRIAL FIBRILLATION |
11 |
0.0001 |
| 228 |
RESPIRATORY RATE INCREASED |
1 |
0.0001 |
| 229 |
HEAVY MENSTRUAL BLEEDING |
1 |
0.0001 |
| 230 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 231 |
LEUKOCYTOSIS |
2 |
0.0001 |
| 232 |
BLOOD THYROID STIMULATING HORMONE INCREASED |
1 |
0.0001 |
| 233 |
OVARIAN CANCER |
1 |
0.0001 |
| 234 |
CONJUNCTIVITIS |
2 |
0.0001 |
| 235 |
MALIGNANT NEOPLASM PROGRESSION |
11 |
0.0001 |
| 236 |
PAIN IN JAW |
3 |
0.0001 |
| 237 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 238 |
HAEMATOTOXICITY |
1 |
0.0001 |
| 239 |
PROTEINURIA |
2 |
0.0001 |
| 240 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 241 |
THROMBOTIC MICROANGIOPATHY |
1 |
0.0001 |
| 242 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 243 |
VITAMIN D DEFICIENCY |
1 |
0.0001 |
| 244 |
HAEMORRHOIDS |
2 |
0.0001 |
| 245 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 246 |
URINARY INCONTINENCE |
3 |
0.0001 |
| 247 |
LEUKOPENIA |
5 |
0.0001 |
| 248 |
SPINAL FRACTURE |
2 |
0.0001 |
| 249 |
STOMATITIS |
6 |
0.0001 |
| 250 |
HYPOTHERMIA |
1 |
0.0001 |
| 251 |
PLEURAL EFFUSION |
6 |
0.0001 |
| 252 |
OEDEMA PERIPHERAL |
12 |
0.0001 |
| 253 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 254 |
HYPERBILIRUBINAEMIA |
1 |
0.0001 |
| 255 |
VENTRICULAR EXTRASYSTOLES |
1 |
0.0001 |
| 256 |
PETECHIAE |
1 |
0.0001 |
| 257 |
TRANSFUSION |
1 |
0.0001 |
| 258 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 259 |
SCRATCH |
1 |
0.0001 |
| 260 |
FULL BLOOD COUNT ABNORMAL |
1 |
0.0001 |
| 261 |
EPISTAXIS |
7 |
0.0001 |
| 262 |
LIVER FUNCTION TEST INCREASED |
2 |
0.0001 |
| 263 |
SKIN LACERATION |
1 |
0.0001 |
| 264 |
SEPTIC SHOCK |
4 |
0.0001 |
| 265 |
OESOPHAGITIS |
1 |
0.0001 |
| 266 |
VOMITING |
43 |
0.0001 |
| 267 |
EYE DISORDER |
3 |
0.0001 |
| 268 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 269 |
SNEEZING |
2 |
0.0001 |
| 270 |
SKIN INFECTION |
1 |
0.0001 |
| 271 |
TRANSIENT ISCHAEMIC ATTACK |
3 |
0.0001 |
| 272 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 273 |
NEOPLASM |
1 |
0.0001 |
| 274 |
SHOCK |
2 |
0.0001 |
| 275 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 276 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 277 |
HYPERKALAEMIA |
3 |
0.0001 |
| 278 |
SPLENOMEGALY |
1 |
0.0001 |
| 279 |
HYPOTENSION |
17 |
0.0001 |
| 280 |
BACTERAEMIA |
1 |
0.0001 |
| 281 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 282 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 283 |
NOCTURIA |
1 |
0.0001 |
| 284 |
RESTLESSNESS |
3 |
0.0001 |
| 285 |
CYTOPENIA |
1 |
0.0001 |
| 286 |
CELLULITIS |
4 |
0.0001 |
| 287 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 288 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 289 |
RESPIRATORY TRACT INFECTION |
2 |
0.0001 |
| 290 |
SARS-COV-2 TEST POSITIVE |
1 |
0.0001 |
| 291 |
HAIR TEXTURE ABNORMAL |
1 |
0.0001 |
| 292 |
MALIGNANT MELANOMA |
1 |
0.0001 |
| 293 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 294 |
NAUSEA |
59 |
0.0001 |
| 295 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 296 |
NEUROPATHY PERIPHERAL |
7 |
0.0001 |
| 297 |
ABDOMINAL PAIN |
17 |
0.0001 |
| 298 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
1 |
0.0001 |
| 299 |
DIVERTICULITIS |
2 |
0.0001 |
| 300 |
DISSEMINATED INTRAVASCULAR COAGULATION |
1 |
0.0001 |
| 301 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
2 |
0.0001 |
| 302 |
RECTAL HAEMORRHAGE |
3 |
0.0001 |
| 303 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 304 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 305 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 306 |
FLUSHING |
7 |
0.0001 |
| 307 |
LIVER FUNCTION TEST ABNORMAL |
2 |
0.0001 |
| 308 |
CHILLS |
8 |
0.0001 |
| 309 |
DEHYDRATION |
9 |
0.0001 |
| 310 |
HEPATIC FAILURE |
2 |
0.0001 |
| 311 |
INSURANCE ISSUE |
1 |
0.0001 |
| 312 |
LUNG INFECTION |
1 |
0.0001 |
| 313 |
ACUTE MYELOID LEUKAEMIA |
1 |
0.0001 |
| 314 |
DYSPNOEA |
36 |
0.0001 |
| 315 |
PYREXIA |
22 |
0.0001 |
| 316 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 317 |
ULCER |
1 |
0.0001 |
| 318 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 319 |
DYSPEPSIA |
6 |
0.0001 |
| 320 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 321 |
LIP SWELLING |
2 |
0.0001 |
| 322 |
TYPE 2 DIABETES MELLITUS |
2 |
0.0001 |
| 323 |
FACE OEDEMA |
1 |
0.0001 |
| 324 |
CANDIDA INFECTION |
1 |
0.0001 |
| 325 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
2 |
0.0001 |
| 326 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 327 |
PNEUMONIA |
19 |
0.0001 |
| 328 |
MUSCULOSKELETAL DISCOMFORT |
1 |
0.0001 |
| 329 |
ECZEMA |
3 |
0.0001 |
| 330 |
HYPERTENSION |
12 |
0.0001 |
| 331 |
DRUG ERUPTION |
1 |
0.0001 |
| 332 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 333 |
DECREASED APPETITE |
13 |
0.0001 |
| 334 |
MYELOSUPPRESSION |
2 |
0.0001 |
| 335 |
OEDEMA |
3 |
0.0001 |
| 336 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 337 |
HYPERHIDROSIS |
7 |
0.0001 |
| 338 |
PANCYTOPENIA |
3 |
0.0001 |
| 339 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 340 |
MUSCULAR WEAKNESS |
6 |
0.0001 |
| 341 |
URINARY TRACT INFECTION |
9 |
0.0001 |
| 342 |
DRY SKIN |
7 |
0.0001 |
| 343 |
HERNIA |
1 |
0.0001 |
| 344 |
EAR PAIN |
1 |
0.0001 |
| 345 |
PAIN IN EXTREMITY |
15 |
0.0001 |
| 346 |
COUGH |
14 |
0.0000 |
| 347 |
DEATH |
43 |
0.0000 |
| 348 |
POLLAKIURIA |
2 |
0.0000 |
| 349 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 350 |
VAGINAL HAEMORRHAGE |
2 |
0.0000 |
| 351 |
SWELLING FACE |
3 |
0.0000 |
| 352 |
COVID-19 |
8 |
0.0000 |
| 353 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 354 |
TOOTH DISORDER |
1 |
0.0000 |
| 355 |
TINNITUS |
2 |
0.0000 |
| 356 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 357 |
GENERAL PHYSICAL HEALTH DETERIORATION |
5 |
0.0000 |
| 358 |
RENAL DISORDER |
2 |
0.0000 |
| 359 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 360 |
DYSPHAGIA |
4 |
0.0000 |
| 361 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 362 |
LOCALISED INFECTION |
1 |
0.0000 |
| 363 |
PRESYNCOPE |
1 |
0.0000 |
| 364 |
NEURALGIA |
1 |
0.0000 |
| 365 |
FATIGUE |
32 |
0.0000 |
| 366 |
HAEMATEMESIS |
1 |
0.0000 |
| 367 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 368 |
DIARRHOEA |
25 |
0.0000 |
| 369 |
HAEMATOMA |
1 |
0.0000 |
| 370 |
ABDOMINAL DISTENSION |
4 |
0.0000 |
| 371 |
ARTHRITIS |
3 |
0.0000 |
| 372 |
BRADYCARDIA |
2 |
0.0000 |
| 373 |
CARDIAC FAILURE |
3 |
0.0000 |
| 374 |
PAIN OF SKIN |
1 |
0.0000 |
| 375 |
CONFUSIONAL STATE |
6 |
0.0000 |
| 376 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 377 |
DRY MOUTH |
3 |
0.0000 |
| 378 |
PNEUMONITIS |
1 |
0.0000 |
| 379 |
MOOD ALTERED |
1 |
0.0000 |
| 380 |
VISION BLURRED |
5 |
0.0000 |
| 381 |
DIZZINESS |
18 |
0.0000 |
| 382 |
FALL |
12 |
0.0000 |
| 383 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 384 |
GASTROINTESTINAL HAEMORRHAGE |
3 |
0.0000 |
| 385 |
OXYGEN SATURATION DECREASED |
2 |
0.0000 |
| 386 |
ANGINA PECTORIS |
1 |
0.0000 |
| 387 |
SEIZURE |
4 |
0.0000 |
| 388 |
INFECTION |
5 |
0.0000 |
| 389 |
DYSPHONIA |
2 |
0.0000 |
| 390 |
NASAL CONGESTION |
2 |
0.0000 |
| 391 |
LABORATORY TEST ABNORMAL |
1 |
0.0000 |
| 392 |
TACHYCARDIA |
3 |
0.0000 |
| 393 |
WHEEZING |
2 |
0.0000 |
| 394 |
GASTROINTESTINAL DISORDER |
3 |
0.0000 |
| 395 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 396 |
EMOTIONAL DISORDER |
1 |
0.0000 |
| 397 |
PARAESTHESIA |
5 |
0.0000 |
| 398 |
CYSTITIS |
1 |
0.0000 |
| 399 |
PRURITUS |
12 |
0.0000 |
| 400 |
FUNGAL INFECTION |
1 |
0.0000 |
| 401 |
SYNCOPE |
3 |
0.0000 |
| 402 |
SKIN DISORDER |
1 |
0.0000 |
| 403 |
URINARY RETENTION |
1 |
0.0000 |
| 404 |
GAIT INABILITY |
1 |
0.0000 |
| 405 |
EYE PRURITUS |
1 |
0.0000 |
| 406 |
HEPATIC ENZYME INCREASED |
2 |
0.0000 |
| 407 |
PAIN |
18 |
0.0000 |
| 408 |
SINUSITIS |
3 |
0.0000 |
| 409 |
NEOPLASM PROGRESSION |
1 |
0.0000 |
| 410 |
HEADACHE |
17 |
0.0000 |
| 411 |
CHRONIC KIDNEY DISEASE |
2 |
0.0000 |
| 412 |
INSOMNIA |
7 |
0.0000 |
| 413 |
ACUTE KIDNEY INJURY |
4 |
0.0000 |
| 414 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 415 |
BACK PAIN |
6 |
0.0000 |
| 416 |
DISORIENTATION |
1 |
0.0000 |
| 417 |
WEIGHT DECREASED |
7 |
0.0000 |
| 418 |
THROMBOSIS |
2 |
0.0000 |
| 419 |
ANXIETY |
7 |
0.0000 |
| 420 |
ASTHENIA |
9 |
0.0000 |
| 421 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 422 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 423 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 424 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
1 |
0.0000 |
| 425 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 426 |
MUSCLE SPASMS |
4 |
0.0000 |
| 427 |
ADVERSE EVENT |
2 |
0.0000 |
| 428 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 429 |
HYPERSENSITIVITY |
4 |
0.0000 |
| 430 |
CARDIAC DISORDER |
2 |
0.0000 |
| 431 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 432 |
DRUG INTOLERANCE |
2 |
0.0000 |
| 433 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 434 |
HYPOGLYCAEMIA |
1 |
0.0000 |
| 435 |
LUNG DISORDER |
1 |
0.0000 |
| 436 |
PRODUCT USE IN UNAPPROVED INDICATION |
5 |
0.0000 |
| 437 |
FLUID RETENTION |
1 |
0.0000 |
| 438 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 439 |
THERAPY CESSATION |
1 |
0.0000 |
| 440 |
NERVOUSNESS |
1 |
0.0000 |
| 441 |
PANCREATITIS |
1 |
0.0000 |
| 442 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 443 |
MEDICATION ERROR |
1 |
0.0000 |
| 444 |
NECK PAIN |
1 |
0.0000 |
| 445 |
BLISTER |
1 |
0.0000 |
| 446 |
FLATULENCE |
1 |
0.0000 |
| 447 |
HERPES ZOSTER |
1 |
0.0000 |
| 448 |
LETHARGY |
1 |
0.0000 |
| 449 |
PALPITATIONS |
2 |
0.0000 |
| 450 |
BONE PAIN |
1 |
0.0000 |
| 451 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 452 |
CONDITION AGGRAVATED |
5 |
0.0000 |
| 453 |
VERTIGO |
1 |
0.0000 |
| 454 |
DISCOMFORT |
1 |
0.0000 |
| 455 |
OFF LABEL USE |
14 |
0.0000 |
| 456 |
GAIT DISTURBANCE |
3 |
0.0000 |
| 457 |
PRODUCT DOSE OMISSION |
1 |
0.0000 |
| 458 |
RENAL FAILURE |
2 |
0.0000 |
| 459 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 460 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 461 |
BURNING SENSATION |
1 |
0.0000 |
| 462 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 463 |
RASH |
6 |
0.0000 |
| 464 |
HOT FLUSH |
1 |
0.0000 |
| 465 |
DIABETES MELLITUS |
1 |
0.0000 |
| 466 |
BLOOD PRESSURE INCREASED |
2 |
0.0000 |
| 467 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 468 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 469 |
TREATMENT FAILURE |
1 |
0.0000 |
| 470 |
TREMOR |
2 |
0.0000 |
| 471 |
URTICARIA |
2 |
0.0000 |
| 472 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 473 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 474 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 475 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 476 |
MYALGIA |
2 |
0.0000 |
| 477 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 478 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 479 |
CHEST PAIN |
2 |
0.0000 |
| 480 |
CONTUSION |
1 |
0.0000 |
| 481 |
PRODUCT DOSE OMISSION ISSUE |
3 |
0.0000 |
| 482 |
ALOPECIA |
2 |
0.0000 |
| 483 |
HEART RATE INCREASED |
1 |
0.0000 |
| 484 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 485 |
MALAISE |
4 |
0.0000 |
| 486 |
WEIGHT INCREASED |
2 |
0.0000 |
| 487 |
DEPRESSION |
2 |
0.0000 |
| 488 |
DRUG INEFFECTIVE |
9 |
0.0000 |
| 489 |
HYPOAESTHESIA |
1 |
0.0000 |
| 490 |
HOSPITALISATION |
1 |
0.0000 |
| 491 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 492 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 493 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 494 |
ERYTHEMA |
1 |
0.0000 |
| 495 |
OVERDOSE |
1 |
0.0000 |
| 496 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 497 |
ARTHRALGIA |
1 |
0.0000 |